Rapid humoral immune responses are required for recovery from haemorrhagic fever with renal syndrome patients

Emerg Microbes Infect. 2020 Dec;9(1):2303-2314. doi: 10.1080/22221751.2020.1830717.

Abstract

ABSTRACT Haemorrhagic fever with renal syndrome (HFRS) following Hantaan virus (HTNV) infection displays variable clinical signs. Humoral responses elicited during HTNV infections are considered important, however, this process remains poorly understood. Herein, we have investigated the phenotype, temporal dynamics, and characteristics of B-cell receptor (BCR) repertoire in an HFRS cohort. The serological profiles were characterized by a lowered expression level of nucleoprotein (NP)-specific antibody in severe cases. Importantly, B-cell subsets were activated and proliferated within the first two weeks of symptom onset and moderate cases reacted more rapidly. BCR analysis in the recovery phase revealed a dramatic increase in the immunoglobulin gene diversity which was more significantly progressed in moderate infections. In severe cases, B-cell-related transcription was lower with inflammatory sets overactivated. Taken together, these data suggest the clinical signs and disease recovery in HFRS patients were positively impacted by rapid and efficacious humoral responses.

Keywords: B cell; Haemorrhagic fever with renal syndrome; Hantaan virus; humoral response; virus infection.

MeSH terms

  • Adult
  • Antibodies, Viral / blood
  • Antibodies, Viral / genetics
  • B-Lymphocytes / immunology
  • China
  • Down-Regulation
  • Female
  • Hantaan virus / immunology*
  • Hemorrhagic Fever with Renal Syndrome / genetics
  • Hemorrhagic Fever with Renal Syndrome / immunology*
  • Humans
  • Immunity, Humoral
  • Male
  • Middle Aged
  • Nucleoproteins / immunology*
  • Receptors, Antigen, B-Cell / genetics*
  • Sequence Analysis, RNA
  • Transcription, Genetic

Substances

  • Antibodies, Viral
  • Nucleoproteins
  • Receptors, Antigen, B-Cell

Grants and funding

This study was funded by the Academic Promotion Programme of Shandong First Medical University (2019PT008 and 2019QL006) and the Key Research and Development Project of Shandong Province (2017GSF19106). Weifeng Shi was supported by the Taishan Scholars Programme of Shandong Province (ts201511056). Weijia Xing was supported by the Young Taishan Scholars Program of Shandong Province (No. tsqn20161046).